232 related articles for article (PubMed ID: 16127052)
61. Antiviral potential of interferon-omega on hepatitis B virus replication in human hepatoma cells.
Hagelstein J; Kist A; Stremmel W; Galle PR
Arzneimittelforschung; 1998 Mar; 48(3):343-7. PubMed ID: 9553691
[TBL] [Abstract][Full Text] [Related]
62. Single nucleotide polymorphisms and functional analysis of MxA promoter region in multiple sclerosis.
Furuyama H; Chiba S; Okabayashi T; Yokota S; Nonaka M; Imai T; Fujii N; Matsumoto H
J Neurol Sci; 2006 Nov; 249(2):153-7. PubMed ID: 16843495
[TBL] [Abstract][Full Text] [Related]
63. Impaired antiviral response in human hepatoma cells.
Keskinen P; Nyqvist M; Sareneva T; Pirhonen J; Melén K; Julkunen I
Virology; 1999 Oct; 263(2):364-75. PubMed ID: 10544109
[TBL] [Abstract][Full Text] [Related]
64. Functional characterization of new allelic polymorphisms identified in the promoter region of the human MxA gene.
Tran Thi Duc T; Desmecht D; Cornet A
Int J Immunogenet; 2013 Aug; 40(4):316-9. PubMed ID: 22985419
[TBL] [Abstract][Full Text] [Related]
65. A comparison of the exponential decay slope between PEG-IFN alfa-2b/ribavirin and IFN alfa-2b/ribavirin combination therapy in patients with chronic hepatitis C genotype 1b infection and a high viral load.
Izumi N; Asahina Y; Kurosaki M; Uchihara M; Nishimura Y; Inoue K; Ueda K; Tsuchiya K; Hamano K; Itakura J; Miyake S
Intervirology; 2004; 47(2):102-7. PubMed ID: 15192274
[TBL] [Abstract][Full Text] [Related]
66. Intrahepatic MxA expression is correlated with interferon-alpha expression in chronic and fulminant hepatitis.
Leifeld L; Ramakers J; Schneiders AM; Dumoulin FL; Sterneck M; Müller A; Sauerbruch T; Spengler U
J Pathol; 2001 Aug; 194(4):478-83. PubMed ID: 11523057
[TBL] [Abstract][Full Text] [Related]
67. Immunomodulatory activities of IFN-gamma1b in combination with type I IFN: implications for the use of IFN-gamma1b in the treatment of chronic HCV infections.
Wang T; Blatt LM; Seiwert SD
J Interferon Cytokine Res; 2006 Jul; 26(7):473-83. PubMed ID: 16800786
[TBL] [Abstract][Full Text] [Related]
68. Development and pharmacokinetics and pharmacodynamics of pegylated interferon alfa-2a (40 kD).
Reddy KR
Semin Liver Dis; 2004; 24 Suppl 2():33-8. PubMed ID: 15346244
[TBL] [Abstract][Full Text] [Related]
69. Reduction of cell viability induced by IFN-alpha generates impaired data on antiviral assay using Hep-2C cells.
de Oliveira ER; Lima BM; de Moura WC; Nogueira AC
J Immunol Methods; 2013 Dec; 400-401():97-105. PubMed ID: 24211646
[TBL] [Abstract][Full Text] [Related]
70. Rapid and simple detection of IFN-neutralizing antibodies in chronic hepatitis C non-responsive to IFN-alpha.
Jorns C; Holzinger D; Thimme R; Spangenberg HC; Weidmann M; Rasenack J; Blum HE; Haller O; Kochs G
J Med Virol; 2006 Jan; 78(1):74-82. PubMed ID: 16299717
[TBL] [Abstract][Full Text] [Related]
71. IFN-alpha induces MxA gene expression in cultured human corneal fibroblasts.
Abrams ME; Balish MJ; Brandt CR
Exp Eye Res; 1995 Feb; 60(2):137-42. PubMed ID: 7540146
[TBL] [Abstract][Full Text] [Related]
72. Type I interferons in the pathogenesis and treatment of canine diseases.
Klotz D; Baumgärtner W; Gerhauser I
Vet Immunol Immunopathol; 2017 Sep; 191():80-93. PubMed ID: 28895871
[TBL] [Abstract][Full Text] [Related]
73. Amino acid differences in interferon-tau (IFN-τ) of Bos taurus Coreanae and Holstein.
Kang D; Ryoo S; Chung B; Lee J; Park S; Han J; Jeong S; Rho G; Hong J; Bae S; Kang T; Kim S; Kim S
Cytokine; 2012 Aug; 59(2):273-9. PubMed ID: 22578803
[TBL] [Abstract][Full Text] [Related]
74. Intracellular staining of Mx proteins in cells from peripheral blood, bone marrow and skin.
al-Masri AN; Werfel T; Jakschies D; von Wussow P
Mol Pathol; 1997 Feb; 50(1):9-14. PubMed ID: 9208807
[TBL] [Abstract][Full Text] [Related]
75. cDNA structures and regulation of two interferon-induced human Mx proteins.
Aebi M; Fäh J; Hurt N; Samuel CE; Thomis D; Bazzigher L; Pavlovic J; Haller O; Staeheli P
Mol Cell Biol; 1989 Nov; 9(11):5062-72. PubMed ID: 2481229
[TBL] [Abstract][Full Text] [Related]
76. PEGylated interferon-alpha2b: a branched 40K polyethylene glycol derivative.
Ramon J; Saez V; Baez R; Aldana R; Hardy E
Pharm Res; 2005 Aug; 22(8):1374-86. PubMed ID: 16078148
[TBL] [Abstract][Full Text] [Related]
77. Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons.
Scagnolari C; Vicenzi E; Bellomi F; Stillitano MG; Pinna D; Poli G; Clementi M; Dianzani F; Antonelli G
Antivir Ther; 2004 Dec; 9(6):1003-11. PubMed ID: 15651759
[TBL] [Abstract][Full Text] [Related]
78. A Novel Cell-based In vitro Assay for Antiviral Activity of Interferons α, β, and γ by qPCR of MxA Gene Expression.
Saber MA; Okasha H; Khorshed F; Samir S
Recent Pat Biotechnol; 2021; 15(1):67-75. PubMed ID: 33183215
[TBL] [Abstract][Full Text] [Related]
79. Antiviral activity of interferon-alpha against hepatitis B virus can be studied in non-hepatic cells and Is independent of MxA.
Rang A; Bruns M; Heise T; Will H
J Biol Chem; 2002 Mar; 277(10):7645-7. PubMed ID: 11781305
[TBL] [Abstract][Full Text] [Related]
80. Biological assays for interferons.
Meager A
J Immunol Methods; 2002 Mar; 261(1-2):21-36. PubMed ID: 11861063
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
